Mayo Clinic Physical Activity Research Center: Metabolomics and Proteomics Analysis Site
Project Number2U24DK112326-07
Former Number5U24DK112326-06
Contact PI/Project LeaderNAIR, K SREEKUMARAN Other PIs
Awardee OrganizationMAYO CLINIC ROCHESTER
Description
Abstract Text
PROJECT SUMMARY
Mayo Clinic Chemical Center (MCC) is funded to perform targeted metabolites and exosome cargo
measurements in samples collected in the Clinical Centers of MoTrPAC.
As advised by the steering committee, we have expended a substantial amount of time developing an innovative
methodology to isolate plasma exosomes and demonstrated reproducibility in multiple experiments, at different
time points and by different laboratories. We propose exosome-based proteome and miRNA analysis in a limited
number of samples. Based on power calculations, we estimated that the proposed number of samples will detect
significant changes in exosome proteome and miRNA responses to aerobic and resistance exercise training. We
will also test a hypothesis that proteome and miRNA release after acute exercise will be different in people who
are highly active in comparison with sedentary people, because the prior exercise training accretes specific
exercise-induced proteins in tissues that will be released during and immediately after both modes of exercise.
These measurements will be done in 140 sedentary people and 110 highly active people and will likely offer
unique new information. In addition, 55 sedentary people will be evaluated at baseline and following 3 months
each of aerobic and resistance training with 30 sedentary controls studied after a 3-month control period.
Secondly, in alignment with metabolomic measurements done at other centers, we will perform measurement of
two quantitative targeted metabolites-amino metabolites and organic acids in plasma and skeletal muscle. These
targeted metabolites are chosen based on their biological relevance to exercise training, and the quantitative
and reproducible data anticipated from our assays would complement large scale metabolites measured in other
Chemical Centers. The targeted metabolome measurement will also offer an opportunity to potentially
understand the biochemical pathways involved in exercise benefits. We chose muscle and plasma
measurements of organic acids representing the substrates of the citric acid flux pathway and amino metabolites
which, based on many preliminary studies, are shown to sensitively respond to exercise with distinct responses
to aerobic and resistance exercise.
Both targeted metabolites in muscle and plasma as well as exosome-based measurements of proteome and
miRNA are anticipated to reveal novel information on how specific exercise programs may benefit physiological
functions. We anticipate that the results from our study in combination with the ongoing multiple omic
measurements in all chemical centers will likely unravel deeper insights on how exercise benefits multiple
organs. Our objective is to advance the translational potential of exosome cargo by administering biological
molecules offering exercise benefits via small vesicles like exosomes to multiple organs in the body. The
metabolites, especially targeted metabolites, are likely biomarkers to monitor responses to the administered
vesicles carrying potentially beneficial molecules.
Public Health Relevance Statement
PROJECT NARRATIVE
Here we propose measurements of molecules that are carried by small vesicles in the circulation delivering
potential beneficial effects. We also are measuring quantitative metabolites which can offer evidence of
exercise benefits and other therapeutic agents potentially carried by the small vesicles in the circulation.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AcuteAdipose tissueAerobic ExerciseAgeAnimalsBiochemical PathwayBiologicalBiological AssayBiological MarkersBiologyBlood Plasma VolumeCOVID-19ChemicalsChildChronicCirculationCitric AcidCitric Acid CycleClinicCollaborationsComplementDataData AnalysesData SetExerciseExhibitsFingerprintFundingGenetic TranscriptionHumanLabelLaboratoriesMeasurementMeasuresMethodologyMicroRNAsMolecular AnalysisMolecular ProfilingMolecular Sieve ChromatographyMonitorMuscleNucleic AcidsOrganParticipantPathway interactionsPatternPersonsPhysical activityPhysiologicalPlasmaPlasma ProteinsProtein BiosynthesisProteinsProteomeProteomicsRadioisotopesRecoveryReproducibilityResearch ActivitySamplingSiteSkeletal MuscleSphingolipidsTestingTherapeutic AgentsTimeTissue SampleTissuesTraining ProgramsUltracentrifugationUnited States National Institutes of HealthVesicleWomanacylcarnitineanimal tissueclinical centerclinical research sitecohortexercise programexercise trainingexosomeexperimental studyinnovationinsightmenmetabolomemetabolomicsmode of exercisemultiple omicsnano-stringnovelorganic acidpreclinical studyprotein profilingresistance exerciseresponsesedentarysextranscriptome sequencingtranslational potentialworking group
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
310
DUNS Number
006471700
UEI
Y2K4F9RPRRG7
Project Start Date
08-December-2016
Project End Date
31-May-2027
Budget Start Date
15-August-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$790,900
Direct Costs
$490,025
Indirect Costs
$300,875
Year
Funding IC
FY Total Cost by IC
2024
NIH Office of the Director
$790,900
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2U24DK112326-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2U24DK112326-07
Patents
No Patents information available for 2U24DK112326-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2U24DK112326-07
Clinical Studies
No Clinical Studies information available for 2U24DK112326-07
News and More
Related News Releases
No news release information available for 2U24DK112326-07
History
No Historical information available for 2U24DK112326-07
Similar Projects
No Similar Projects information available for 2U24DK112326-07